|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
25,230,000 |
Market
Cap: |
100.92(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$5.37 - $14.07 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Verastem is a late stage development biopharmaceutical company, with ongoing registration directed trials, focused on developing and commercializing medicines for patients battling cancer. Co.'s product candidates, VS-6766 and defactinib, are being investigated in both preclinical and clinical studies for the treatment of various solid tumors. VS-6766 is an orally available small molecule rapidly accelerated fibrosarcoma/ mitogen-activated protein kinase kinase clamp. Defactinib is an oral small molecule inhibitor of Focal Adhesion Kinase and proline-rich tyrosine kinase that is being evaluated as a potential combination therapy for various solid tumors.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
1,735 |
21,833 |
25,311 |
129,609 |
Total Sell Value |
$18,442 |
$258,319 |
$292,764 |
$349,328 |
Total People Sold |
4 |
4 |
4 |
4 |
Total Sell Transactions |
9 |
20 |
37 |
60 |
End Date |
2024-02-29 |
2023-11-28 |
2023-05-30 |
2022-05-30 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Stuglik Brian M |
Chief Executive Officer |
|
2020-03-27 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
371,000 |
|
- |
|
Ridgeback Capital Management Llc |
10% Owner |
|
2020-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
5,515,151 |
10,068,243 |
|
- |
|
Shah Rajeev M. |
10% Owner |
|
2020-03-03 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
18,604,651 |
|
-55% |
|
Stuglik Brian M |
Chief Executive Officer |
|
2019-07-29 |
4 |
A |
$0.00 |
$0 |
D/D |
270,000 |
270,000 |
|
- |
|
Gagnon Robert E. |
Chief Financial Officer |
|
2019-06-21 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
151,000 |
|
- |
|
Barberich Timothy J |
Director |
|
2019-03-15 |
4 |
B |
$3.21 |
$105,930 |
D/D |
33,000 |
168,000 |
2.39 |
- |
|
Barberich Timothy J |
Director |
|
2018-09-28 |
4 |
B |
$7.31 |
$36,550 |
D/D |
5,000 |
135,000 |
2.39 |
- |
|
Paterson Dan |
Chief Operating Officer |
|
2018-09-28 |
4 |
B |
$7.00 |
$21,000 |
D/D |
3,000 |
23,286 |
2.74 |
- |
|
Stuglik Brian M |
Director |
|
2018-09-28 |
4 |
B |
$7.30 |
$7,303 |
D/D |
1,000 |
1,000 |
2.39 |
- |
|
Kauffman Michael |
Director |
|
2018-09-28 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
8,000 |
|
- |
|
Kauffman Michael |
Director |
|
2018-09-28 |
4 |
B |
$7.49 |
$29,960 |
D/D |
4,000 |
4,000 |
2.39 |
- |
|
Forrester Robert |
President and CEO |
|
2018-09-28 |
4 |
B |
$7.00 |
$14,000 |
D/D |
2,000 |
221,234 |
2.81 |
- |
|
Lobacki Joseph M |
Executive VP & CCO |
|
2018-09-28 |
4 |
B |
$7.30 |
$21,900 |
D/D |
3,000 |
10,700 |
2.74 |
- |
|
Paterson Dan |
Chief Operating Officer |
|
2018-09-27 |
4 |
B |
$7.01 |
$14,056 |
D/D |
2,000 |
20,286 |
2.74 |
- |
|
Forrester Robert |
President and CEO |
|
2018-09-27 |
4 |
B |
$7.00 |
$73,500 |
D/D |
10,500 |
219,234 |
2.81 |
- |
|
Gagnon Robert E. |
Chief Financial Officer |
|
2018-08-28 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
51,000 |
|
- |
|
Bloom Steven H. |
Chief Strategy Officer |
|
2018-06-08 |
4 |
B |
$5.98 |
$17,940 |
D/D |
3,000 |
3,500 |
2.74 |
- |
|
Lobacki Joseph M |
Executive VP & CCO |
|
2018-06-08 |
4 |
B |
$5.79 |
$44,583 |
D/D |
7,700 |
7,700 |
2.74 |
- |
|
Barberich Timothy J |
Director |
|
2017-12-05 |
4 |
B |
$3.95 |
$239,125 |
D/D |
60,538 |
130,000 |
2.39 |
- |
|
Rowinsky Eric K |
Director |
|
2017-09-05 |
4 |
B |
$3.84 |
$7,680 |
I/I |
2,000 |
2,000 |
2.1 |
- |
|
Barberich Timothy J |
Director |
|
2017-05-15 |
4 |
B |
$2.45 |
$73,500 |
D/D |
30,000 |
69,462 |
2.39 |
- |
|
Chiapponi Joseph |
Vice President of FinanceOffic |
|
2016-04-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
6,502 |
|
- |
|
Kauffman Michael |
Director |
|
2015-08-24 |
4 |
S |
$6.46 |
$13,374 |
D/D |
(2,070) |
0 |
|
- |
|
Paterson Dan |
Chief Operating Officer |
|
2015-08-01 |
4 |
D |
$7.30 |
$46,392 |
D/D |
(6,355) |
18,286 |
|
- |
|
Forrester Robert |
President & CEO |
|
2015-08-01 |
4 |
D |
$7.30 |
$59,787 |
D/D |
(8,190) |
218,734 |
|
- |
|
168 Records found
|
|
Page 5 of 7 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|